Beating Cancer from the Grocery Store Revised Audiolibro Por James McCraw arte de portada

Beating Cancer from the Grocery Store Revised

Cancer Stem Cells

 Muestra de Voz Virtual

$0.00 por los primeros 30 días

Prueba por $0.00
Escucha audiolibros, podcasts y Audible Originals con Audible Plus por un precio mensual bajo.
Escucha en cualquier momento y en cualquier lugar en tus dispositivos con la aplicación gratuita Audible.
Los suscriptores por primera vez de Audible Plus obtienen su primer mes gratis. Cancela la suscripción en cualquier momento.

Beating Cancer from the Grocery Store Revised

De: James McCraw
Narrado por: Virtual Voice
Prueba por $0.00

Escucha con la prueba gratis de Plus

Compra ahora por $14.99

Compra ahora por $14.99

Confirma la compra
la tarjeta con terminación
Cambiar método de pago
Al confirmar tu compra, aceptas las Condiciones de Uso de Audible y el Aviso de Privacidad de Amazon. Impuestos a cobrar según aplique.
Cancelar
Background images

Este título utiliza narración de voz virtual

Voz Virtual es una narración generada por computadora para audiolibros..

Acerca de esta escucha

 The only way to be cancer free is by killing the Cancer Stem Cells. The tumor has a small part that is called the Cancer Stem Cells (usually 1% - 5%), It is the target. Most Oncologists focus on the tumor. That is what they are taught by Big Pharma. It is not the Oncologist fault, they believe it. There are different ways to kill the Cancer Stem Cells. I chose the anti-inflammatory diet.

Killing the Cancer Stem Cells are preventive if you don’t have cancer or if you have cancer. It does not matter as long as you kill the Cancer Stem Cells. If you do the traditional cancer therapy (SOC), chemotherapy and radiation, your cancer is coming back. It might not be immediately, but it will come back with a vengeance.

Doctors use surgery, chemotherapy, radiation, immunotherapy, and targeted therapies. ivermectin, fentanyl…. They typically don’t use natural products. Doctors will lose licenses to practice medicine if they don’t prescribe other than conventional therapies, namely chemotherapy and radiation.

The following is from Pub Med:
Cancer stem cells (CSCs) comprise the subpopulation of tumor bulk and acquire resistant to conventional therapies and are considered as the primary tumor initiator cells. Nowadays, the tumor heterogeneity originated from CSCs, and its progenitors are accepted as a mortifying drawback in front of the cancer therapies. However, escalating knowledge gained from studies investigating the biology of CSCs will open up new frames for targeted therapies and decrease the chance of recurrence of the disease. In this review, the general understanding of CSCs and current studies were discussed briefly. Considering the latest data collected from studies of CSCs, defining the tumor heterogeneity and tumor microenvironment comprehensively will be very important to step up the cancer research.

Recently it is considered that there is a small population of cells with stem cell property not only in leukemia but also in solid cancer. These cells show the ability of self-renewal and multi-potential differentiation, and can initiate and maintain a tumor. Since the first prospective identification of cancer stem cells in solid cancers the cancer stem cell hypothesis has reemerged as a research topic of increasing interest. It postulates that solid cancers are organized hierarchically with a small number of cancer stem cells driving tumor growth, repopulation after injury and metastasis. Since the first prospective identification of cancer stem cells in solid cancers the cancer stem cell hypothesis has reemerged as a research topic of increasing interest. It postulates that solid cancers are organized hierarchically with a small number of cancer stem cells driving tumor growth, repopulation after injury and metastasis. They give rise to differentiated progeny, which lack these features. The model predicts that for any therapy to provide cure, all cancer stem cells have to be eliminated while the survival of differentiated progeny is less critical. In this review we discuss recent reports challenging the idea of a unidirectional differentiation of cancer cells. These reports provide evidence supporting the idea that non-stem cancer cells exhibit a remarkable degree of plasticity that allows them to re-acquire cancer stem cell traits, especially in the context of radiation therapy. We summarize conditions under which differentiation is reversed and discuss the current knowledge of the underlying mechanisms.
adbl_web_global_use_to_activate_webcro805_stickypopup
Todavía no hay opiniones